Pharmanutra S.p.A. (BIT:PHN)
Italy flag Italy · Delayed Price · Currency is EUR
81.90
-0.10 (-0.12%)
Jul 28, 2026, 9:53 AM CET

Pharmanutra Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
102.25136.25118.32101.9683.3968.84
Revenue Growth
17.16%15.15%16.05%22.27%21.15%17.31%
Gross Profit
97.3128.17114.7794.1276.6364.6
Operating Income
31.4930.3127.3723.3623.0418.69
Net Income
21.022016.6112.8315.0513.77
Earnings Per Share
2.202.091.731.331.561.42
EPS Growth
28.66%20.81%30.08%-14.74%9.86%-2.07%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Italy
78.9576.6370.2463.5657.9747.81
Rest of World
52.0148.2539.3431.6123.420.3
Medical Instruments
7.056.825.925.032.03-
Total
138.01131.69115.5100.283.3968.11

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2930.6228.9725.1226.8633.94
Total Debt
19.120.5124.2728.0217.736.35
Net Cash (Debt)
9.9110.14.7-2.99.1427.59
Net Cash Growth
47.74%114.91%---66.89%44.14%
Net Cash Per Share
1.041.050.49-0.300.942.85

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
19.4519.5620.4212.0917.4720.41
Capital Expenditures
-3.43-3.13-4.25-13.25-26.16-4.99
Free Cash Flow
16.0216.4316.17-1.16-8.6915.43
Free Cash Flow Growth
-22.24%1.59%---52.49%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
95.16%94.07%97.00%92.30%91.89%93.85%
Operating Margin
30.80%22.25%23.13%22.91%27.63%27.15%
Pretax Margin
30.71%22.16%22.95%22.81%28.08%27.32%
Profit Margin
20.48%14.62%13.99%12.58%18.04%20.01%
FCF Margin
15.66%12.06%13.67%-1.14%-10.42%22.41%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.2001.2001.0000.8500.8000.710
Dividend Per Share Growth
20.00%20.00%17.65%6.25%12.68%5.97%
Dividend Yield
1.46%1.84%1.56%1.41%1.14%0.89%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
37.2625.9831.4542.4139.9453.10
Forward PE
31.8223.4725.2532.3638.7953.54
P/FCF Ratio
49.0231.6532.30--47.32
PS Ratio
5.653.824.425.327.2010.60